ReviewCancers2021
NPM-ALK: A Driver of Lymphoma Pathogenesis and a Therapeutic Target.
Elissa Andraos et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
16 papers cite it
this papercites it
ReviewCancers2021
Elissa Andraos et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.